Related Experiment Video

Updated: Mar 26, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Effects of Malignant Melanoma Initiating Cells on T-Cell Activation

Tobias Schatton1,2, Ute Schütte2,3, Markus H Frank4,5

  • 1Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|January 21, 2016
PubMed

Insights

Malignant melanoma-initiating cells (MMICs) can evade immune responses, hindering cancer treatment. New methods allow studying MMIC immunomodulatory effects to improve melanoma therapies.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Human malignant melanoma often evades immune responses, limiting treatment efficacy.
  • Understanding immune evasion mechanisms is crucial for developing better melanoma therapies.
  • Malignant melanoma-initiating cells (MMICs) are key players in immune evasion and tumor progression.

Purpose of the Study:

  • To characterize the immunoregulatory effects of purified MMICs compared to bulk melanoma populations.
  • To investigate the mechanisms of melanoma immune evasion and immunotherapy resistance.
  • To adapt existing immune assays for studying tumor-mediated immunomodulation.

Main Methods:

  • Co-culturing purified MMICs and melanoma bulk populations with syngeneic or allogeneic lymphocytes.
  • Utilizing [3H]thymidine incorporation assays to measure lymphocyte proliferation.
  • Employing enzyme-linked immunosorbent spot (ELISPOT) and ELISA assays to assess immune responses.

Main Results:

  • Established methodologies to characterize immunoregulatory effects of MMICs.
  • Demonstrated the successful adaptation of alloimmune assays for studying tumor-mediated immunomodulation.
  • Provided a framework for investigating MMIC-driven immune evasion in melanoma.

Conclusions:

  • MMICs possess distinct immunomodulatory capacities that contribute to melanoma immune evasion.
  • The developed methodologies enable detailed analysis of MMIC-lymphocyte interactions.
  • Further research into MMIC functions can inform novel melanoma treatment strategies.
Keywords:
Antitumor immunityCancer stem cellCytokinesELISAELISPOTImmune escapeImmunologyImmunomodulationImmunoregulatoryMelanomaPBMCProliferationT cell activationT effector cellsTumor initiating cell[3H]thymidine incorporation

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K
A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.0K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K